These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32415570)

  • 1. Empowering newborn screening programs in African countries through establishment of an international collaborative effort.
    Therrell BL; Lloyd-Puryear MA; Ohene-Frempong K; Ware RE; Padilla CD; Ambrose EE; Barkat A; Ghazal H; Kiyaga C; Mvalo T; Nnodu O; Ouldim K; Rahimy MC; Santos B; Tshilolo L; Yusuf C; Zarbalian G; Watson MS;
    J Community Genet; 2020 Jul; 11(3):253-268. PubMed ID: 32415570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022.
    Fakhkhari M; Salih I; Maazaz N; Nembaware V; Munung NS; Matimba A; Chala S; Belmouden A; Chappell K; Mutesa L; El-Kamah G; Oumzil H; Baassi L; Abbas Y; Alimohamed MZ; Ramsay M; Williams S; Benabdellah K; Idaghdour Y; Wonkam A; Sadki K
    Am J Trop Med Hyg; 2024 Jun; 110(6):1279-1284. PubMed ID: 38697089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry: Value and Unique Challenges in Developing Regions.
    Hom LA; Martin GR
    Int J Neonatal Screen; 2020 Sep; 6(3):74. PubMed ID: 33123641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on Building Sustainable Newborn Screening Programs for Sickle Cell Disease: Experience from Tanzania.
    Bukini D; Nkya S; McCurdy S; Mbekenga C; Manji K; Parker M; Makani J
    Int J Neonatal Screen; 2021 Feb; 7(1):. PubMed ID: 33652550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilising the 'Getting to Outcomes
    Inusa BPD; Anie KA; Lamont A; Dogara LG; Ojo B; Ijei I; Atoyebi W; Gwani L; Gani E; Hsu L
    Int J Neonatal Screen; 2018 Dec; 4(4):33. PubMed ID: 33072954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.
    Osaigbovo II; Govender NP; Jordan AM; Bongomin F; Meya DB; Kanyua A; Mashedi OM; Koffi D; Loyse A; Sturny-Leclère A; Gangneux JP; Denning DW; Chiller T; Cornely OA; Oladele RO
    Med Mycol; 2024 Jan; 62(1):. PubMed ID: 38154488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
    Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
    Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International collaborations in cancer control and the Third International Cancer Control Congress.
    Micheli A; Sanz N; Mwangi-Powell F; Coleman MP; Neal C; Ullrich A; Travado L; Santini LA; Grassi L; De Lorenzo F; Costa A; Dangou JM; Bisanti L; Seniori Costantini A; Abu-Rmeileh N; Kamal M; Federico M; Saracci R; Rennert G; Stefanini A; Cavalli F; Cazap E; Redmond K; O'Reilly S; Muti P; Casali P; Gatta G; Ferrari A; Koifman S; Bah E; Pastore G; Barr R; Lombardo C; Frazzingaro C; Ciampichini R; Baili P;
    Tumori; 2009; 95(5):579-96. PubMed ID: 19999949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations.
    Smart LR; Hernandez AG; Ware RE
    Semin Hematol; 2018 Apr; 55(2):102-112. PubMed ID: 30616806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Realities for a Sickle Cell Disease Control Strategy in the World Health Organization African Region].
    Ngasia B; Tshilolo L; Loko G; Vodouhe C; Wamba G; Gonzalez JP
    Med Trop Sante Int; 2021 Mar; 1(1):. PubMed ID: 35685395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experts and NGOs discuss the implementation of the Dakar / Ngor Declaration and the Cairo Programme of Action in Abidjan.
    Afr Popul Newsl; 1995; (67):1. PubMed ID: 12319532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A; Habib AG; Munube D; Lamorde M
    BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of participatory needs assessment: in-service training in health education for child survival in Africa.
    Oladepo O; Adeniyi J; Parker K; Steckler A; Foushee V
    Hygie; 1991; 10(4):40-5. PubMed ID: 1662667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.